These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1151076)

  • 1. Immune mechanisms in leukemia: suppression of cellular immunity by drugs and x-irradiation.
    Martinez D; Lukasewycz OA; Murphy WH
    J Immunol; 1975 Sep; 115(3):724-9. PubMed ID: 1151076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Einstein AB; Fass L; Fefer A
    Cancer Res; 1975 Mar; 35(3):492-6. PubMed ID: 1078784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune mechanisms in leukemia: protective capacity of the major lymphoid cell compartments.
    Lukasewycz OA; Duffey PS; Murphy WH
    J Immunol; 1976 Apr; 116(4):976-81. PubMed ID: 1082909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenetic mechanisms in immune polioencephalomyelitis: induction of disease in immunosuppressed mice.
    Duffey PS; Martinez D; Abrams GD; Murphy WH
    J Immunol; 1976 Feb; 116(2):475-81. PubMed ID: 1249421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lactoferrin on the methotrexate-induced suppression of the cellular and humoral immune response in mice.
    Artym J; Zimecki M; Kruzel ML
    Anticancer Res; 2004; 24(6):3831-6. PubMed ID: 15736418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune mechanisms in leukemia: evaluation of immunocompetent cell populations.
    Lukasewycz OA; Martinez D; Murphy WH
    J Immunol; 1975 May; 114(5):1491-6. PubMed ID: 1091703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: requirement for T cells.
    Berenson JR; Einstein AB; Fefer A
    J Immunol; 1975 Jul; 115(1):234-8. PubMed ID: 1080165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of cyclophosphamide, 6-mercaptopurine, azathiopurine and methotrexate. Relative effects on the humoral and the cellular immune response in the mouse.
    Otterness IG; Chang YH
    Clin Exp Immunol; 1976 Nov; 26(2):346-54. PubMed ID: 991462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide.
    Sy MS; Miller SD; Claman HN
    J Immunol; 1977 Jul; 119(1):240-4. PubMed ID: 68972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclophosphamide on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).
    Havas HF; Schiffman G
    Cancer Res; 1981 Mar; 41(3):801-7. PubMed ID: 7459867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide.
    Mokyr MB; Dray S
    Cancer Res; 1983 Jul; 43(7):3112-9. PubMed ID: 6850619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
    Schlick E; Ruffmann R; Chirigos MA; Welker RD; Herberman RB
    Cancer Res; 1985 Mar; 45(3):1108-14. PubMed ID: 3871661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enhancement of immune response by an antitumor agent, cyclophosphamide].
    Nitta K; Tanaka T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):706-13. PubMed ID: 2938546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cyclophosphamide on immunological control mechanisms.
    Turk JL; Parker D; Cameron AE
    Int J Tissue React; 1984; 6(3):205-11. PubMed ID: 6480267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of certain mechanisms of antigen-specific suppression of the immune response].
    Pisarev VM; Stukalov SV
    Biull Eksp Biol Med; 1981 Aug; 92(8):61-3. PubMed ID: 6170364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization against transplantable leukemia impaired in copper-deficient mice.
    Lukasewycz OA; Prohaska JR
    J Natl Cancer Inst; 1982 Aug; 69(2):489-93. PubMed ID: 6955548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide.
    Berd D; Maguire HC; Mastrangelo MJ
    Cancer Res; 1984 Nov; 44(11):5439-43. PubMed ID: 6488195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide-sensitive and cyclophosphamide-resistant suppressor cells in the immune response to alloantigens.
    Bonavida B; Hutchinson IV; Thomas A
    Transplant Proc; 1979 Mar; 11(1):874-7. PubMed ID: 313108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of immune responses after methotrexate administration.
    Orbach-Arbouys S; Castes M
    Immunology; 1979 Feb; 36(2):265-9. PubMed ID: 35464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral immunization causes antigen-specific cell-mediated suppression of an intestinal IgA response.
    Koster FT; Pierce NF
    J Immunol; 1983 Jul; 131(1):115-9. PubMed ID: 6190901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.